ImmunityBio, Inc. IBRX Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Total Revenue by Product | |||||
| Other revenues | $306K-48.6% | $595K-4.3% | $622K+159% | $240K— | |
| Product revenue, net | $112.98M+698% | $14.15M— | $0— | $0— | |
| Revenue by Geography | |||||
| Europe | $278K-47.6% | $531K-10.2% | $591K+198% | $198K-64.7% | |
| U.S. | $113.01M+695% | $14.21M+45,752% | $31K-26.2% | $42K-88.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does ImmunityBio, Inc. break its business down?
- ImmunityBio, Inc. (IBRX) reports total revenue by product across 2 parts — Other revenues and Product revenue, net. Each is extracted from the segment footnotes and tracked over time.
- Where does ImmunityBio, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in ImmunityBio, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
